Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Rating) was the recipient of a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 5,970,000 shares, an increase of 34.2% from the March 15th total of 4,450,000 shares. Approximately 14.4% of the company’s shares are sold short. […]